Friday, September 03, 2010
   
Text Size

Title Filter 

Display # 
1 Actavis receives FDA approval to market ADHD drug 09.02.10
2 Eisai announces initiation of Alzheimer's drug study 09.02.10
3 Transdel Pharmaceuticals Presents Phase 3 Study Data on Ketotransdel® at World Pain Congress in Montreal, Canada 09.02.10
4 Addex drug-candidate effective in Alzheimer's disease model 09.01.10
5 Eisai Announces the Start of the First Clinical Study of BAN2401, Novel Monoclonal Antibody Targeting Neurotoxic Protofibrils Believed to Cause Alzheimer's Disease 09.01.10
6 Forest Laboratories and Gedeon report results from phase II depression trial 09.01.10
7 Reckitt Benckiser wins FDA approval for opioid dependence drug 09.01.10
8 Nabi Biopharmaceuticals Announces Long-Term Manufacturing Agreement 09.01.10
9 Nabi Biopharmaceuticals Announces Long-Term Manufacturing Agreement With Diosynth RTP 09.01.10
10 Clinic Roundup 08.31.10
11 Heart drug may prevent cocaine relapse 08.31.10
12 Study Findings Show Value of Dietary Supplement SAMe in Treatment of Adults With Major Depressive Disorders 08.31.10
13 MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence 08.31.10
14 21 Drugs Facing FDA Approval Decisions 08.31.10
15 Naurex's Novel Antidepressant GLYX-13 Recognized as One of Windhover's Top 10 Neuroscience Projects to Watch 08.31.10
16 Poland Pharmaceuticals and Healthcare Report Q4 2010 08.31.10
17 Clinic Roundup 08.30.10
18 RECKITT BENCKISER GROUP PLC - Receives FDA Approval for Suboxone Sublingual Film 08.30.10
19 Neurotech Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial for AAD-2004, a Potent Spin Trapping Molecule and Microsomal Prostaglandin E Synthase-1 Inhibitor, Targeting Alzheimer's, Parkinson's, and Lou Gehrig's Disease 08.30.10
20 Pre and Post-Operative Use of Caldolor® (Ibuprofen) Injection Significantly Reduces Pain and Opioid Use in Newly Published Study 08.30.10
21 Patient Recruitment Demographics Help Drive 72% of Companies' Clinical Strategies 08.30.10
22 Cell Therapy Foundation Calls for Additional Research, Extensive Clinical Trials 08.30.10
23 BEMA Buprenorphine Phase 2 Study Results Selected for Presentation at Pain Week 2010 08.30.10
24 Clinic Roundup 08.29.10
25 Forest Laboratories, Inc. and Gedeon Richter Plc Announce Results from a Phase II Study of Cariprazine for the Treatment of Bipolar Depression 08.29.10

Page 1 of 27

Main Menu

FREE Daily Update!

Sign up for the BHC DAILY UPDATE to get breaking behavioral healthcare news delivered daily to your inbox!

    Name:
Email:
 

Information for...

Treatment Center Finder

Search Results 0
1. Select your Country:
2. Enter your Zip:
3. Show listings within:
mi km

4. Select your search Category

Select a BHC Disorder

Behavioral Health Central © Copyright 2010, All Rights Reserved

Login Form